Journal articles

The following is a listing of recent articles about mesothelioma in medical journals that are available through PubMed, a search engine of the National Library of Medicine. The journal title, date, and page numbers follow the title, along with a link to PubMed.

1. Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma.
   
   Click here for abstract
   
   
2. High Dose Radiation Therapy Improves Survival in Patients with Mesothelioma.
   
   Click here for abstract
   
   
3. Novel Complimentary Therapies Boost Role of Surgery for Mesothelioma Cancer.
   
   Click here for abstract
   
   
4. Gene-modified PA1-STK cells home to tumor sites in patients with malignant pleural mesothelioma.

Harrison LH Jr, Schwarzenberger PO, Byrne PS, Marrogi AJ, Kolls JK, McCarthy KE
Department of Surgery, Louisiana State University Health Sciences Center, New Orleans.

http://www.ncbi.nlm.nih.gov


5. Combined Resection, Intraperitoneal Chemotherapy and Whole Abdominal Radiation for the Treatment of Peritoneal Mesothelioma

Keohan ML, Chabot J, Fountain K, Antman KH, Taub RN
Columbia University Divisions of Medical Oncology (MLK, KHA, RNT), Surgery (JC), Radiation Oncology (KF), Columbia-Presbyterian Medical Center, New York, NY

http://www.cancer.med.umich.edu


6. Phase I and Pharmacologic Study of Sequences of Gemcitabine and the Multitargeted Anifolate Agent in Patients With Advanced Solid Tumors

Adjei AA, Erlichman C, Sloan JA, Reid JM, Pitot HC, Goldberg RM, Peethambaram P, Atherton P, Hanson LJ, Alberts SR, Jett J
Department of Oncology, Mayo Clinic and Foundation, Rochester, MN.

J Clin Oncol 2000 Apr. 8;18(8):1748-1757
http://www.ncbi.nlm.nih.gov


7. Pleuropneumonectomy in the treatment of malignant pleural mesothelioma

Grondin SC, Sugarbaker DJ
Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Chest 1999 Dec;116(6 Suppl):450S-454S

Click here for the home page

---

Selected Press Releases

1. Update on Phase III Program of ONCONASE ® for The Treatment of Patients with Unresectable Malignant Mesothelioma
   
   Press Release from Alfacell, April 3, 2002



2. Orphan Drug Designation Granted for Treatment of Mesothelioma and Ovarian Cancer
   
   Press Release from NeoPharm, Inc., February 14, 2002



3. Encouraging Survival in Patients With Advanced Malignant Mesothelioma Treated With Alfacell's ONCONASE ®
   
   Press Release from Alfacell, Jan 22, 2002

---

Interviews With Mesothelioma Experts

Interviews with mesothelioma doctors, a patient, and an attorney to provide perspective on what mesothelioma is, how it's treated and what it's like to live with the disease